BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, Yu BH, Du YQ. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol 2011; 17(11): 1501-1506 [PMID: 21472111 DOI: 10.3748/wjg.v17.i11.1501]
URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1501.htm
Number Citing Articles
1
Yu-ying Lei, Jin-yu Huang, Qiong-rui Zhao, Nan Jiang, Hui-mian Xu, Zhen-ning Wang, Hai-qing Li, Shi-bo Zhang, Zhe Sun. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literatureWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1132-5
2
XR Hu, YX Hu, HR Fu, LX Sheng, WJ Huang, KY Hu, H Huang, WZ Xie. Diffuse Large B-Cell Lymphoma with Concurrent Gastric Adenocarcinoma: Case Report and Literature ReviewJournal of International Medical Research 2011; 39(5): 2051 doi: 10.1177/147323001103900554
3
Zong-Qiong Sun, Yu-Xi Ge, Lin Chen, Jie Li, Lin-Fang Jin, Zhi-Hui Xie. The feasibility of low-dose CT perfusion imaging in gastric cancerJournal of X-Ray Science and Technology 2017; 25(5): 847 doi: 10.3233/XST-17282
4
Jennifer Jeung, Roshan Patel, Lizette Vila, Dara Wakefield, Chen Liu. Quantitation of HER2/neu Expression in Primary Gastroesophageal Adenocarcinomas Using Conventional Light Microscopy and Quantitative Image AnalysisArchives of Pathology & Laboratory Medicine 2012; 136(6): 610 doi: 10.5858/arpa.2011-0371-OA
5
Nobumitsu Shiina, Atsushi Okuno, Yasuo Wakabayashi, Hisao Koshikawa. A Complete Response Case of Gastric Cancer to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 and TrastuzumabNihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 2013; 38(2): 307 doi: 10.4030/jjcs.38.307
6
Seyed-Hamid Madani, Ali Rahmati, Edris Sadeghi, Sedighe Khazaei, Masoud Sadeghi, Mehrdad Payandeh, Nasrin Amirifard. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction AdenocarcinomaAsian Pacific Journal of Cancer Prevention 2015; 16(17): 7755 doi: 10.7314/APJCP.2015.16.17.7755
7
Sang-Woo Lim, Hye-Ran Kim, Hwan-Young Kim, Jung-Wook Huh, Young-Jin Kim, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang, Hyeong-Rok Kim, Myung-Geun Shin. Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factorCellular Oncology 2013; 36(4): 311 doi: 10.1007/s13402-013-0136-6
8
Zongqiong Sun, Xiaofang Cheng, Yuxi Ge, Lin Shao, Yinghua Xuan, Gen Yan. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinomaGastric Cancer 2018; 21(3): 413 doi: 10.1007/s10120-017-0763-0
9
Fang Li, Guiqing Meng, Bibo Tan, Zihao Chen, Qiang Ji, Xiaoxiao Wang, Chang Liu, Shuyao Niu, Yong Li, Yueping Liu. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosisPathology - Research and Practice 2021; 217: 153280 doi: 10.1016/j.prp.2020.153280
10
G. Jomrich, S. F. Schoppmann. Targeted therapy in gastric cancerEuropean Surgery 2016; 48(5): 278 doi: 10.1007/s10353-016-0389-1
11
Maria McIntire, Mark Redston. Targeted Therapies and Predictive Markers in Epithelial Malignancies of the Gastrointestinal TractArchives of Pathology & Laboratory Medicine 2012; 136(5): 496 doi: 10.5858/arpa.2011-0167-RA
12
Toshihiro Tajirika, Yoshihisa Tokumaru, Kohei Taniguchi, Nobuhiko Sugito, Nobuhisa Matsuhashi, Manabu Futamura, Kazuyoshi Yanagihara, Yukihiro Akao, Kazuhiro Yoshida. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer CellsInternational Journal of Molecular Sciences 2018; 19(7): 2005 doi: 10.3390/ijms19072005
13
Li-Hua Jiang, Ying-Li Hao, Jing-Wei Zhu. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2019; 43(3): 282 doi: 10.1016/j.clinre.2018.09.011
14
Dominique Werner, Achim Battmann, Kristina Steinmetz, Tobin Jones, Tiffany Lamb, Michele Martinez, Hans-Michael Altmannsberger, Salah-Eddin Al-Batran. The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testingJournal of Translational Medicine 2014; 12(1): 160 doi: 10.1186/1479-5876-12-160
15
Y. Wang, L. He, Y. Cheng. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysisClinical and Translational Oncology 2018; 20(2): 212 doi: 10.1007/s12094-017-1711-5
16
Xiaoyan Liu, Xiaoling Wang, Bo Wang, Guoping Ren, Wei Ding. HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer CasesApplied Immunohistochemistry & Molecular Morphology 2016; 24(7): 459 doi: 10.1097/PAI.0000000000000219
17
Ahmed Abdel Hadi, Ali El Hindawi, Amal Hareedy, Heba Khalil, Ranya Al Ashiry, Shady Elia, Ahmed Sadek, Mona Magdy, Rafatt Atta, Amgad Anas, Hisham Bakr, Olfat Hammam. Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian PatientsOpen Access Macedonian Journal of Medical Sciences 2016; 4(4): 535 doi: 10.3889/oamjms.2016.104
18
Daisuke Kotani, Kohei Shitara. Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancerTherapeutic Advances in Medical Oncology 2021; 13: 175883592098651 doi: 10.1177/1758835920986518
19
Kan Wang, Jing Ruan, Qirong Qian, Hua Song, Chenchen Bao, Xueqing Zhang, Yifei Kong, Chunlei Zhang, Guohan Hu, Jian Ni, Daxiang Cui. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancerJournal of Nanobiotechnology 2011; 9(1) doi: 10.1186/1477-3155-9-23
20
Arnaldo N. S. Silva, Jordy Coffa, Varsha Menon, Lindsay C. Hewitt, Kakoli Das, Yohei Miyagi, Dan Bottomley, Hayley Slaney, Toru Aoyama, Wolfram Mueller, Tomio Arai, Iain B. Tan, Niantao Deng, Xiu B. Chan, Patrick Tan, Akira Tsuburaya, Kentaro Sakamaki, Jeremy D. Hayden, Takaki Yoshikawa, Ilse Zondervan, Suvi Savola, Heike I. Grabsch. Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node MetastasisAnnals of Surgery 2018; 267(1): 114 doi: 10.1097/SLA.0000000000002042
21
Kwang Kuk Park, Song I Yang, Kyung Won Seo, Ki Young Yoon, Sang Ho Lee, Hee Kyung Jang, Yeon Myeong Shin. Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative ResectionGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/946359
22
Ya’nan Yang, Chenchen Wang, Congqi Dai, Xinyang Liu, Wenhua Li, Mingzhu Huang, Xiaoying Zhao, Dongmei Ji, Jin Li, Weijian Guo. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1Acta Biochimica et Biophysica Sinica 2021; 53(5): 547 doi: 10.1093/abbs/gmab026
23
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto, Kazuo Shirouzu. Molecular targeting to treat gastric cancerWorld Journal of Gastroenterology 2014; 20(38): 13741-13755 doi: 10.3748/wjg.v20.i38.13741
24
Nicola Carlomagno, Paola Incollingo, Vincenzo Tammaro, Gaia Peluso, Niccolò Rupealta, Gaetano Chiacchio, Maria Laura Sandoval Sotelo, Gianluca Minieri, Antonio Pisani, Eleonora Riccio, Massimo Sabbatini, Umberto Marcello Bracale, Armando Calogero, Concetta Anna Dodaro, Michele Santangelo. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric CancerBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7869802
25
M. Pirrelli, M. L. Caruso, M. Di Maggio, R. Armentano, A. M. Valentini. Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?Digestive Diseases and Sciences 2012;  doi: 10.1007/s10620-012-2357-3
26
Feng-Hua Wang, Lin Shen, Jin Li, Zhi-Wei Zhou, Han Liang, Xiao-Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu-Jing Zhang, Xiang-Lin Yuan, Tian-Shu Liu, Guo-Xin Li, Qi Wu, Hui-Mian Xu, Jia-Fu Ji, Yuan-Fang Li, Xin Wang, Shan Yu, Hao Liu, Wen-Long Guan, Rui-Hua Xu. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancerCancer Communications 2019; 39(1): 10 doi: 10.1186/s40880-019-0349-9
27
Yoshiki Kataoka, Hiroshi Okabe, Akihiko Yoshizawa, Sachiko Minamiguchi, Kenichi Yoshimura, Hironori Haga, Yoshiharu Sakai. HER2 expression and its clinicopathological features in resectable gastric cancerGastric Cancer 2013; 16(1): 84 doi: 10.1007/s10120-012-0150-9
28
Hai Cui, Ying Cheng, Su-Zhou Piao, Yun-Jie Xu, Hong-Hua Sun, Xian Cui, Xiang-Zi Li, Song-Nan Zhang, Long-Zhen Piao, Yong-Min Jin, Zhen-hua Lin, Xiong-Hu Shen. Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell linesCancer Cell International 2014; 14(1) doi: 10.1186/1475-2867-14-10
29
Sun Zongqiong, Li Xiaohong, Cai Wei, Zhou Jiangfeng, Ge Yuxi, Xie Zhihui, Jin Linfang, Pu Yong, Yan Gen. CT perfusion imaging of the stomach: a quantitative analysis according to different degrees of adenocarcinoma cell differentiationClinical Imaging 2016; 40(3): 558 doi: 10.1016/j.clinimag.2015.11.006
30
G Jomrich, SF Schoppmann. Targeting HER 2 and angiogenesis in gastric cancerExpert Review of Anticancer Therapy 2016; 16(1): 111 doi: 10.1586/14737140.2016.1121110
31
Byung Woog Kang, Dakeun Lee, Ho Young Chung, Jae Ho Han, Young-Bae Kim. Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancerJournal of Cancer Research and Clinical Oncology 2013; 139(11): 1835 doi: 10.1007/s00432-013-1503-4
32
Maciej Ciesielski, Wiesław Janusz Kruszewski, Urszula Śmiałek, Jakub Walczak, Mariusz Szajewski, Jarosław Szefel, Jacek Wydra, Krzysztof Kawecki. The HER2 Gene and HER2 Protein Status and Chromosome 17 Polysomy in Gastric Cancer Cells in Own MaterialApplied Immunohistochemistry & Molecular Morphology 2015; 23(2): 113 doi: 10.1097/PAI.0000000000000070
33
Zong-Qiong Sun, Gen Yan, Yu-Xi Ge, Jie Li, Lin-Fang Jin, Zhi-Hui Xie, Peng Zhao. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?Journal of X-Ray Science and Technology 2017; 25(6): 981 doi: 10.3233/XST-17271
34
Azza Abdel-Aziz, Rehab Allah Ahmed, Afaf Taha Ibrahiem. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stagesAnnals of Diagnostic Pathology 2017; 30: 1 doi: 10.1016/j.anndiagpath.2017.05.003
35
Hao Wu, Zhenzhai Cai, Guangrong Lu, Shuguang Cao, He Huang, Yi Jiang, Weijian Sun. Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysisTumori Journal 2017; 103(3): 249 doi: 10.5301/tj.5000444
36
Ling Shan, Jianming Ying, Ning Lu. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese populationDiagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-76
37
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinomaVirchows Archiv 2014; 465(2): 145 doi: 10.1007/s00428-014-1597-3
38
D. Santini, B. Vincenzi, F. Pantano, G. Schiavon, G. Tonini. ‘All action no talk’: the role of HER2/neu in adjuvant therapy choice for gastric cancerAnnals of Oncology 2013; 24(7): 1715 doi: 10.1093/annonc/mdt172
39
Narikazu Boku. HER2-positive gastric cancerGastric Cancer 2014; 17(1): 1 doi: 10.1007/s10120-013-0252-z
40
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, Quoc Dat Ngo, Thi Phuong Thao Doan, Sao Trung Nguyen, Anh Tu Thai, Van Thanh Nguyen. HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese PatientJournal of Pathology and Translational Medicine 2017; 51(4): 396 doi: 10.4132/jptm.2017.04.24
41
Nick Baniak, Jenna-Lynn Senger, Shahid Ahmed, S. C. Kanthan, Rani Kanthan. Gastric biomarkers: a global reviewWorld Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0969-3
42
Huiying Sun, Rui Zhou, Yannan Zheng, Zhaowei Wen, Dingling Zhang, Dongqiang Zeng, Jianhua Wu, Zhenhua Huang, Xiaoxiang Rong, Na Huang, Li Sun, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapyOncogene 2021; 40(34): 5342 doi: 10.1038/s41388-021-01932-0
43
Carolina Cruz-Reyes, Armando Gamboa-Dominguez. Her2 Amplification in Gastric Cancer Is a Rare Event Restricted to the Intestinal PhenotypeInternational Journal of Surgical Pathology 2013; 21(3): 240 doi: 10.1177/1066896913481055
44
Ali Zisan Genc, Resit Dogan Koseoglu, Akgul Arici, Osman Demir. HER-2/neu gene analysis on endoscopic biopsy samples and gastric resection materials in gastric carcinomasRussian Open Medical Journal 2019; 8(4) doi: 10.15275/rusomj.2019.0410
45
Saba El-Gendi, Iman Talaat, Mona Abdel-Hadi. HER-2/Neu Status in Gastric Carcinomas in a Series of Egyptian Patients and Its Relation to Ki-67 ExpressionOpen Journal of Pathology 2015; 5(04): 101 doi: 10.4236/ojpathology.2015.54014
46
Yixing Jiang. Impact of Genetic Targets on Cancer TherapyAdvances in Experimental Medicine and Biology 2013; 779: 55 doi: 10.1007/978-1-4614-6176-0_3
47
Emel Ebru Pala, Umit Bayol, Alp Ozguzer, Ozlem Akman. HER2 status in gastric cancer: A comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™)Pathology - Research and Practice 2013; 209(9): 548 doi: 10.1016/j.prp.2013.05.008
48
Bo Wang, Ke Sun, Yinying Zou. Comparison of a Panel of Biomarkers Between Gastric Primary Cancer and the Paired Krukenberg TumorApplied Immunohistochemistry & Molecular Morphology 2017; 25(9): 639 doi: 10.1097/PAI.0000000000000347
49
Eduardo Henrique Cunha Neves Filho, Adriana Pinheiro Bezerra Pires, Rosane Oliveira de Sant'Ana, Silvia Helena Barem Rabenhorst, Carlos Gustavo Hirth, Maria Do Perpétuo Socorro Saldanha da Cunha. The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinomaAPMIS 2018; 126(5): 389 doi: 10.1111/apm.12840
50
Shigehiro Koganemaru, Kohei Shitara. Antibody–drug conjugates to treat gastric cancerExpert Opinion on Biological Therapy 2021; 21(7): 923 doi: 10.1080/14712598.2020.1802423
51
Junhun Cho, Jiyun Jeong, Jiyoun Sung, Chang Ohk Sung, Kyoung-Mee Kim, Cheol Keun Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Sung Kim. A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced StagesAnnals of Surgical Oncology 2013; 20(S3): 477 doi: 10.1245/s10434-012-2818-0
52
Takahiro Ishii, Kohei Shitara. Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancerExpert Review of Anticancer Therapy 2021; : 1 doi: 10.1080/14737140.2021.1982698
53
Rui Li, Jing Li, Xiaopeng Wang, Pan Liang, Jianbo Gao. Detection of gastric cancer and its histological type based on iodine concentration in spectral CTCancer Imaging 2018; 18(1) doi: 10.1186/s40644-018-0176-2